Funds holding PROCESSA PHARMACEUTICALS INC
4 funds declare a position · 0 ETFs and 4 other funds · 70.5K $ · US74275C4033
Each line carries its report date.
| Rank | Fund | Shares | Value | Weight | |
|---|---|---|---|---|---|
| 1 | Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 14,665 | 31.8K $ | 0.00 % | as of Feb 28, 2026 · Original filing |
| 2 | VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 12,729 | 32.1K $ | as of Mar 31, 2026 · Original filing | |
| 3 | Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 2,088 | 4.5K $ | as of Feb 28, 2026 · Original filing | |
| 4 | Fidelity Total Market Index Fund Fidelity Concord Street Trust | 969 | 2.1K $ | as of Feb 28, 2026 · Original filing |
Institutional managers
8 managers declare this company to the SEC (Form 13F). These positions are not counted in the totals above: a manager and its own funds file separately.
| Manager | Shares | Value | |
|---|---|---|---|
| Connective Capital Management, LLC | 70,736 | 178.6K $ | as of Mar 31, 2026 |
| Stonepine Capital Management, LLC | 55,000 | 138.9K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 24,908 | 62.8K $ | as of Mar 31, 2026 |
| UBS Group AG | 2,531 | 6.4K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 918 | 2.3K $ | as of Mar 31, 2026 |
| CITIGROUP INC | 14 | 35 $ | as of Mar 31, 2026 |
| JONES FINANCIAL COMPANIES LLLP | 7 | 17 $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 6 | 15 $ | as of Mar 31, 2026 |